Company Overview and News

 
Trading ideas: IJM, Pesona Metro, Borneo Aqua, Sapura Energy

2018-09-05 thestar.com.my
KUALA LUMPUR: JF Apex expects IJM Corp Bhd , Pesona Metro Holdings Bhd , Borneo Aqua Harvest Bhd and Sapura Energy Bhd to be among the stocks to watch on Wednesday.
5158 8311 0098

 
KLCI seen drifting sideways, defend 1,800-level

2018-09-04 theedgemarkets
KUALA LUMPUR (Sept 5): The FBM KLCI is seen drifting sideways today, in line with the weaker overnight close at most global markets.
7007 1368 8311 0098

 
IJM Corp, Pesona Metro, Borneo Aqua, Ark Resources, Sapura Energy and UEM Edgenta

2018-09-04 theedgemarkets
KUALA LUMPUR (Sept 4): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Sept 5) may include the following: IJM Corp Bhd, Pesona Metro Holdings Bhd, Borneo Aqua Harvest Bhd, Ark Resources Bhd, Sapura Energy Bhd and UEM Edgenta Bhd
7007 1368 5158 8311 0098

 
Borneo Aqua Harvest proposes 1-for-1 bonus issue

2018-09-04 theedgemarkets
KUALA LUMPUR (Sept 4): Borneo Aqua Harvest Bhd has proposed a bonus issue of up to 939 million shares, on the basis of one bonus share for every existing share.
0098

1
KLCI to trade range bound, move between 1,790 – 1,800

2018-08-01 theedgemarkets
KUALA LUMPUR (Aug 2): The FBM KLCI is expected to trade range bound today within a tight band of between 1,790 – 1,800.
5216 5754 6556 AAPL 5088 8117 0098 5254

 
DRB-Hicom, Malakoff, Bahvest, Boustead Plantations, LKL, MHB, Ann Joo, Utusan, Poly Glass Fibre, Datasonic, Apex Equity and AirAsia

2018-08-01 theedgemarkets
KUALA LUMPUR (Aug 1): Based on corporate announcements and news flow today, companies in focus on Thursday (Aug 2) may include: DRB-Hicom Bhd, Malakoff Corp Bhd, Borneo Aqua Harvest Bhd, Boustead Plantations Bhd, LKL International Bhd, Malaysia Marine and Heavy Engineering Holdings Bhd, Ann Joo Resources Bhd, Utusan Melayu (Malaysia) Bhd, Poly Glass Fibre (M) Bhd, Datasonic Group Bhd, Apex Equity Holdings Bhd and AirAsia Group Bhd.
5216 5754 6556 5088 MYPRY 8117 5014 0098 5254

 
Borneo Aqua's new gold plant starts commercial operation

2018-08-01 theedgemarkets
KUALA LUMPUR (Aug 1): Borneo Aqua Harvest Bhd (Bahvest) said it has successfully commissioned its gold processing plant.
BSMAF 0098 1818

 
Borneo Aqua starts commercial gold production

2018-08-01 thestar.com.my
KUALA LUMPUR: Borneo Aqua Harvest Bhd said the group’s gold processing plant in Sabah has started operation and yielded its maiden gold dore bar.
BSMAF 0098 1818

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...